Commitment to PAH
A commitment to PAH for the most personal of reasons
United Therapeutics proudly devotes its energy and resources to the PAH Initiative. We’re committed to the PAH Initiative because from the outset, PAH has been personal to us.
United Therapeutics was founded by the parents of a child who was diagnosed with PAH. We understand the fears, hopes, and challenges that await people affected by PAH. It’s a core part of our identity.
For more than 20 years, United Therapeutics has been conducting clinical trials and developing treatments for PAH and related conditions. That commitment is as strong today as it has ever been, and United Therapeutics offers a bold pipeline full of promise.
Yet, we recognize that PAH is much more than treatments and promises. It’s your life—and that’s what drives our commitment.